Insider Shareholders with Direct Ownership of Cns Pharmaceuticals, Inc. (CNSP)
This section provides a comprehensive overview of the insiders with direct ownership of Cns Pharmaceuticals, Inc. (CNSP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CNS Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John M Climaco
Chief Executive Officer |
225,666 | 0 | 215,676 $25,881 | 6 |
Feb 01, 2024
Added 43.59%
|
|
Christopher Downs
Chief Financial Officer |
139,787 | 0 | 103,438 $12,412 | 7 |
Feb 01, 2024
Added 39.19%
|
|
Jerzy Gumulka
Director |
43,006 | 0 | 43,006 $5,160 | 3 |
Feb 01, 2024
Added 43.66%
|
|
Carl Anthony Evans
Director |
37,083 | 0 | 33,458 $4,014 | 2 |
Feb 01, 2024
Added 49.91%
|
|
Jeffry R. Keyes
Director |
11,100 | 0 | 11,100 $1,332 | 1 |
Mar 07, 2022
Added 50.0%
|